TP53 and cancer: Although the roles of genetic alterations such as APC, TP53, KRAS, and key signaling pathways such as Wnt, RAS-MAPK, and PI3K in driving CRC have been extensively studied2,3, the incidence and mortality of CRC are still at the forefront of all types of cancer and have been on the rise.